{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-24-001824","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.231271+00:00","generated_at":"2026-05-30T03:22:48.751938+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lipella Pharmaceuticals effects 1-for-8 reverse stock split","bullets":["Reverse split effective Nov 7, 2024; every 8 shares converted to 1 share.","No fractional shares issued; holders paid cash for fractional interests.","Authorized share count unchanged; options and warrants adjusted proportionally.","Common stock trades split-adjusted on Nasdaq Capital Market starting Nov 8.","New CUSIP number for common stock is 53630L 209."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-24-001824","json":"https://secwatch.observer/filing/0001753926-24-001824.json","markdown":"https://secwatch.observer/filing/0001753926-24-001824.md","text":"https://secwatch.observer/filing/0001753926-24-001824.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624001824/0001753926-24-001824-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624001824/g084539_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:22:48.751938+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"89d2d5eec250db8a93f4016dd495afab1b4ef746","claim":"LIPELLA PHARMACEUTICALS INC.: effected a one-for-eight reverse stock split of common stock (effective 2024-11-07).","evidence_excerpt":"On November 7, 2024, Lipella Pharmaceuticals Inc. (the “Company”), acting pursuant to authority received at an annual meeting of its stockholders on September 10, 2024, filed with the Secretary of State of the State of Delaware a certificate of amendment (the “Charter Amendment”) to its second amended and restated certificate of incorporation, as amended (the “Certificate of Incorporation”), which effected a one-for-eight reverse stock split (the “Reverse Stock Split”) of all of the Company’s outstanding shares of common stock, par value $0.0001 per share (the “Common Stock”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624001824/0001753926-24-001824-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-11-07"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}